ADDED
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
As of March 10, 2026, the Registrant had 8,911,250 Class A ordinary shares, par value $0.0001 each, issued and outstanding.
MARKET FOR REGISTRANT S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 73 ITEM 6.
BUSINESS Overview We are a blank check company incorporated on March 22, 2024 as a Cayman Islands exempted company formed for the purpose of effecting a business combination with one or more businesses, which we refer to throughout this Annual Report as our initial business combination.
Perceptive Advisors has invested in over 144 private companies since 2013 and in 2025 met with approximately 200 potential business combination targets.
Stone continues to serve on the board of directors of Immatics N.V.
and its wholly owned acquisition subsidiaries completed an all-cash tender offer to acquire all outstanding shares of common stock of Cerevel for $45.00 per share.
Following the closing of the acquisition, shares of Cerevel s common stock were delisted from Nasdaq on August 1, 2024.
In June 2021, ARYA Sciences Acquisition Corp III consummated its initial business combination with Nautilus Biotechnology, Inc.
The closing price of the common stock of Nautilus on Nasdaq on March 10, 2026 was $2.43.
REMOVED
As of March 14, 2025, the Registrant had 8,911,250 Class A ordinary shares, par value $0.0001 each, issued and outstanding.
MARKET FOR REGISTRANT S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 63 ITEM 6.
BUSINESS Overview We are a recently organized blank check company incorporated on March 22, 2024 as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Annual Report as our initial business combination.
Perceptive Advisors has invested in over 142 private companies since 2013 and in 2024 met with over 200 private companies in evaluation of private growth financing rounds, crossovers, and pre-IPO analysis.
Stone continues to serve on the supervisory board of Immatics N.V.
Additionally, in October 2020, ARYA Sciences Acquisition Corp II consummated its initial business combination with Cerevel Therapeutics.
On December 6, 2023, Cerevel entered into an Agreement and Plan of Merger (the Merger Agreement ) with AbbVie Inc., a Delaware corporation ( Parent ), Symphony Harlan LLC, a Delaware limited liability company and wholly owned subsidiary of Parent ( Intermediate Holdco ), and Symphony Harlan Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of Intermediate Holdco ( Merger Sub ), pursuant to which, and on the terms and subject to the conditions thereof, Merger Sub will merge with and into Cerevel, with Cerevel surviving as a wholly owned subsidiary of Parent.
Michael Altman continues to serve on the board of directors of Nautilus.
The closing price of the common stock of Nautilus on Nasdaq on March 11, 2025 was $1.13.
The closing price of the common stock of Adagio on Nasdaq on March 11, 2025 was $1.04.